Physician profile
Judy Sequeira
NPI 1487604849
$883.27
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $132 · 2021: $17.26 · 2022: $19.21 · 2023: $32.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $168.16 | 2019 | |
| Merck Sharp & Dohme LLC | $162.78 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $128.04 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $114.61 | 2019-2020 | |
| Foundation Medicine, INC. | $85.87 | 2019-2023 | |
| Eisai INC. | $66.33 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $31.16 | 2021-2023 | Precisetumor |
| Takeda Pharmaceuticals U.S.A., INC. | $17.61 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $16.42 | 2019 | |
| Taiho Oncology, INC. | $15.26 | 2019 | |
| Novocure INC. | $14.37 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.62 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $13.12 | 2019 | |
| Daiichi Sankyo INC. | $13.02 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.57 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Sequeira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.